Browse Title Index
Issue | Title | |
Vol 7, No 2 (2011) | Edytorial | Details PDF (Polish) |
Marek Pawlicki | ||
Vol 7, No 5 (2011) | Edytorial | Details PDF (Polish) |
Marek Pawlicki | ||
Vol 7, Supp. E (2011) | Edytorial | Abstract PDF (Polish) |
Aleksandra Łacko, Iwona Głogowska | ||
Vol 10, Supp. A (2014) | Efektywna 46-miesięczna terapia celowana pacjenta z zaawansowanym rakiem nerkowokomórkowym | Details PDF (Polish) |
Artur Drobniak | ||
Vol 18, No 3 (2022) | Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results | Abstract PDF HTML |
Roman Dubiański | ||
Vol 11, Supp. C (2015) | Effective control of symptoms of advanced prostatic carcinoma — a case report of a patient treated with abiraterone acetate | Abstract PDF (Polish) |
Łukasz Głogowski | ||
Vol 11, No 2 (2015) | Effective sequential chemoradiotherapy of a patient with locally advanced melanoma of the naso-ethmoidal massive | Abstract PDF (Polish) HTML (Polish) |
Kamila Patrycja Tabaka, Krystian Kidrycki, Marek Wojtukiewicz, Ewa Sierko | ||
Vol 13, No 6 (2017) | Effectiveness of nivolumab in an elderly patient with metastatic BRAF-negative melanoma originating from the anal region | Abstract PDF |
Jacek Calik | ||
Vol 19, No 5 (2023) | Effects of the changes between preand post-treatment 18F-FDG PET-CT volumetric parameters on overall survival in pleural mesothelioma | Abstract PDF HTML |
Faris Tüzün, Senar Ebinç, Muhammet Ali Kaplan, İhsan Kaplan, Halil Kömek, Zeynep Oruç, Şadiye Kemal Tuzcu, Bekir Taşdemir | ||
Vol 19, No 3 (2023) | Efficacy of chemoimmunotherapy in a lung adenocarcinoma patient with mutations in the KRAS and STK11 | Abstract PDF HTML |
Natalia Krzyżanowska, Paweł Krawczyk, Izabela Chmielewska, Tomasz Jankowski, Kamila Wojas-Krawczyk, Janusz Milanowski | ||
Vol 19, No 4 (2023) | Efficacy of pemetrexed plus a platinum rechallenge in the treatment of pleural mesothelioma | Abstract PDF HTML |
Zuhat Urakçı, Senar Ebinç, Zeynep Oruç, Ziya Kalkan, Muhammet Ali Kaplan, Mehmet Küçüköner, Abdurrahman Işıkdoğan | ||
Vol 13, No 4 (2017) | Efficacy of regorafenib in gastrointestinal stromal tumors (GISTs) – a case report. | Abstract PDF HTML |
Iwona Ługowska, Anna Dawidowska, Anna Klimczak, Piotr Rutkowski | ||
Vol 6, Supp. A (2010) | Efficiency of liposomal doxorubicin in the treatment of advanced breast cancer after completed conventional doxorubicin cumulative dose | Abstract PDF (Polish) |
Michał Tomala | ||
Ahead of print | EGFR gene mutation and association with carcinoembryonic antigen status in non-small cell lung cancer — a cross-sectional study | Abstract PDF |
Lam Van Ngo, Toan Khanh Nguyen, Hung Duc Tran, Uyen Tu Thi Nguyen, Hien Thu Thi Tran, Thanh Van Le | ||
Vol 10, Supp. G (2014) | EGFR mutated (exon 21) metastatic lung adenocarcinoma in female patient treated with erlotinib — case report | Abstract PDF (Polish) |
Krzysztof Leśniewski-Kmak | ||
Vol 19, No 5 (2023) | EGFR mutation and ALK fusion-positive non-small cell lung cancer: a multicenter prospective cohort study in Nagano Prefecture, Japan | Abstract PDF HTML |
Takashi Kobayashi, Shintaro Kanda, Kazunari Tateishi, Nobutoshi Morozumi, Ryouhei Yamamoto, Fumiaki Yoshiike, Hideaki Takizawa, Munetaka Takada, Manabu Yamamoto, Kenichi Nishie, Takasuna Keiichiro, Toshihiko Agatsuma, Mineyuki Hama, Hozumi Tanaka, Akemi Matsuo, Akio Morikawa, Masayuki Hanaoka, Tomonobu Koizumi | ||
Vol 10, No 4 (2014) | EGFR tyrosine kinase inhibitors in the first-line or second-line treatment of patients with EGFR gene activating mutation | Abstract PDF (Polish) |
Magdalena Knetki-Wróblewska, Adam Płużański, Maciej Krzakowski | ||
Vol 5, No 3 (2009) | EGFR tyrosine kinase inhibitors in the treatment of brain metastases in non-small cell lung cancer | Abstract PDF (Polish) |
Renata Duchnowska | ||
Vol 8, No 1 (2012) | Elderly patients treatment with non-small-cell lung cancer | Abstract PDF (Polish) |
Dariusz M. Kowalski, Maciej Krzakowski | ||
Vol 4, No 2 (2008) | Emerging therapeutic options for breast cancer chemotherapy during pregnancy | Abstract PDF (Polish) |
Olivier Mir, Paul Berveiller, Stanislas Ropert, François Goffinet, Gérard Pons, Jean-Marc Treluyer, François Goldwasser | ||
Vol 16, No 2 (2020) | Encorafenib in combination with binimetinib — a new therapeutic option with a favourable safety profile in the treatment of patients with advanced BRAF mutation-positive melanoma | Abstract PDF |
Paulina Jagodzińska-Mucha, Piotr Rutkowski | ||
Ahead of print | : Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience | Abstract PDF |
Marek Gełej, Patryk Zając, Maria Dąbrowska, Anna Dejws-Wątróbowska, Bogumiła Galińska, Łukasz Galus, Agnieszka Gwóźdź-Cieślik, Katarzyna Hetman, Maciej Kawecki, Mateusz Malik, Joanna Streb, Katarzyna Wierzbicka, Piotr Wiosek, Barbara Radecka | ||
Ahead of print | Encorafenib plus cetuximab in patients with BRAFV600E-mutated metastatic colorectal cancer — Polish multicenter experience | Abstract PDF |
Marek Gełej, Patryk Zając, Maria Dąbrowska, Anna Drejws-Wątróbska, Bogumiła Galińska, Łukasz Galus, Agnieszka Gwóźdź-Cieślik, Katarzyna Hetman, Maciej Kawecki, Mateusz Malik, Joanna Streb, Katarzyna Wierzbicka, Piotr Wiosek, Barbara Radecka | ||
Vol 11, No 3 (2015) | Endocrinological view on lung cancer | Abstract PDF (Polish) HTML (Polish) |
Magdalena Potempa, Paweł Jonczyk, Marzena Zalewska-Ziob | ||
Vol 17, No 3 (2021) | Endometriosis and risk of ovarian cancer | Abstract PDF |
Yavor Kornovski, Yonka Atanasova, Stoyan Kostov, Stanislav Slavchev, Angel Danchev Yordanov | ||
326 - 350 of 1151 Items | << < 9 10 11 12 13 14 15 16 17 18 > >> |